Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04252950 · ClinicalTrials.gov registry record · NA

Community-based Exercise Following Revascularization for PAD

A NA study of Peripheral Artery Disease, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04252950 is a NA study of Peripheral Artery Disease that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 30 participants, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04252950, a NA study of Peripheral Artery Disease, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The primary goal of this clinical trial is to evaluate whether a community-based structured exercise therapy (CB-SET) intervention, which could be accessible and easily disseminated, adds benefit to peripheral artery disease (PAD) patients undergoing revascularization (REVASC) to improve their function and cardiovascular health.

Conditions Studied

Interventions

  • BEHAVIORAL CB-SET
  • PROCEDURE Revascularization

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-04-08
Est. Completion 2026-08-31
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04252950

The ClinicalTrials.gov registry entry for NCT04252950 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (76% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which CB-SET is the first listed.

NCT04252950 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04252950 about?

NCT04252950 is a clinical study titled "Community-based Exercise Following Revascularization for PAD". The primary goal of this clinical trial is to evaluate whether a community-based structured exercise therapy (CB-SET) intervention, which could be accessible and easily disseminated, adds benefit to peripheral artery disease (PAD) patients undergoing revascularization (REVASC) to improve their funct...

What is the current status of trial NCT04252950?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-04-08. Estimated completion is 2026-08-31.

What conditions does trial NCT04252950 study?

This clinical trial studies the following conditions: Peripheral Artery Disease.

What interventions are being tested in trial NCT04252950?

The interventions under investigation include: CB-SET (BEHAVIORAL), Revascularization (PROCEDURE).

Who is sponsoring clinical trial NCT04252950?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04252950 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.